The uterus called the ‘karbapai’ in Tamil is the organ where a baby grows during pregnancy. It sits in the lower part of the abdomen and is lined on the inside by a layer of tissue called the endometrium. Most uterine cancers begin in this inner lining, which is why they are also called endometrial cancers.
When cells in this lining start multiplying without control, a tumour forms. In many cases, this happens gradually and produces recognisable signs particularly changes in bleeding patterns that give women a genuine window of opportunity to act early.
Endometrial cancer is the more common type. It tends to produce symptoms early usually abnormal bleeding and when caught at that stage, it responds very well to treatment. Uterine sarcoma is rarer, often grows faster, and may not produce obvious symptoms until it has grown larger. The distinction is confirmed through biopsy, and your treatment plan will be built around the specific type.
Uterine cancer is one of the most common gynaecological cancers in India. It most commonly affects women between the ages of 50 and 65, though it can occur younger particularly in women with certain hormonal or genetic risk factors. In Chennai and across Tamil Nadu, cases are increasingly being detected earlier as awareness around abnormal bleeding improves. The good news: when uterine cancer is detected at an early stage, the outcomes are genuinely very good. This is one cancer where timely action makes a profound difference.
Most women who are eventually diagnosed with uterine cancer had noticed something before they sought help. In many cases, the symptom had been present for weeks or even months before a doctor was consulted. This is not a criticism it reflects how easy it is to explain away a symptom when you are not sure what it means. If you are reading this because a symptom has been nagging at you, please take it seriously.
Abnormal vaginal bleeding is the most important early warning sign of uterine cancer. This includes:
Many women assume post menopausal bleeding is a hormonal change or nothing serious. Sometimes it is. But it should always be investigated, because it is also the most common and earliest symptom of uterine cancer and when caught at this stage, the cancer is usually still localised and highly treatable.
These symptoms can have many causes, most of which are not cancer. But the only way to know is to get checked. A symptom that keeps returning over two weeks or more deserves a proper evaluation.
When uterine cancer has grown or spread, symptoms become more difficult to ignore:
At this stage, treatment is still possible and can still significantly extend life and improve its quality but the options are more complex. This is why earlier detection matters so much.
When uterine cancer is confirmed, the next step is process of finding out how far the cancer has spread. Staging guides every treatment decision. It also tells us what outcome to realistically expect. Knowing your stage is not about assigning a number to your condition .It is about making sure the treatment plan is as accurate and effective as possible.
The cancer is found only within the uterus and has not spread to nearby organs or lymph nodes. This is the earliest stage and carries the best outcomes. Surgery alone usually a hysterectomy may be all that is needed. Five-year survival rates at Stage I are above 90%.
The cancer has extended from the uterus into the cervix (the lower part of the uterus that connects to the vagina), but has not spread beyond. Surgery remains the cornerstone of treatment, sometimes followed by radiation therapy to reduce the chance of recurrence. Outcomes at this stage are still very good.
The cancer has spread to nearby tissue such as the ovaries, fallopian tubes, vagina, or lymph nodes in the pelvis but has not reached distant organs. Treatment at this stage typically involves a combination of surgery, radiation, and chemotherapy. Outcomes vary based on the extent of spread and the specific type of cancer.
Stage IV means the cancer has reached the bladder, rectum, or organs outside the pelvis such as the lungs or liver. Treatment at this stage focuses on controlling the disease, reducing symptoms, and maintaining quality of life for as long as possible. Chemotherapy, targeted therapy, immunotherapy, and hormonal therapy all have roles to play. Many Stage IV patients continue to live meaningful, active lives with the right treatment.
Uterine cancer does not have a single cause. It develops when a combination of factors hormonal, genetic, and lifestyle-related creates an environment where abnormal cell growth can begin. Understanding your risk factors does not predict your future; it helps you and your doctor make smarter decisions about monitoring and prevention.
The endometrium is sensitive to the hormone oestrogen. When oestrogen levels are high relative to progesterone a state called oestrogen dominance the lining of the uterus can thicken abnormally over time, increasing the chance of cancerous change.
Situations that can lead to this hormonal imbalance include: never having been pregnant, late menopause, early onset of periods, and use of oestrogen-only hormone replacement therapy without progesterone.
These are risk factors, not certainties. Many women with all of these factors never develop uterine cancer. But awareness means earlier action.
Women with Lynch syndrome , a hereditary condition that increases the risk of several cancers, including colorectal and uterine have a significantly higher lifetime risk of developing uterine cancer. If you have a first-degree relative (mother, sister) who was diagnosed with uterine, colon, or ovarian cancer before the age of 50, genetic counselling is worth discussing. A BRCA gene mutation, more commonly associated with breast and ovarian cancer, also carries some elevated risk for uterine cancer in certain subtypes.
There is no universal population screening for uterine cancer the way there is for cervical cancer. However, certain women benefit from proactive monitoring:
If you fall into any of these categories and have not had a recent gynaecological review, this is the right time to schedule one.
Diagnosis is a step by step process. No single test on its own confirms or rules out uterine cancer. The process moves from your symptoms to examination, then to imaging, and finally to tissue analysis. Each step is necessary and builds on the one before it.
Your consultation will begin with a detailed conversation about your symptoms when they started, how often they occur, whether anything makes them better or worse, and your personal and family medical history. This conversation is not a formality. The pattern of your symptoms tells an experienced oncologist a great deal before any test is done.
A pelvic examination follows the doctor feels for any abnormalities in the uterus or surrounding structures.
A transvaginal ultrasound gives a close-up view of the uterus and measures the thickness of the endometrium. A thickened endometrial lining particularly in a post-menopausal woman is a key indicator that further investigation is needed. The endometrial biopsy is the definitive step. A small sample of tissue is taken from the uterine lining usually done in an outpatient setting without the need for general anaesthesia and sent for pathological analysis. This confirms whether cancer cells are present, and if so, what type and grade they are.
Once cancer is confirmed, imaging is done to determine how far it has spread:
These scans are what allow your oncologist to assign a stage and build an accurate treatment plan.
If you have received a diagnosis and are unsure about the recommended treatment or if you simply want to feel more confident before proceeding a second opinion is always appropriate. Experienced gynaecologic oncologists expect this and welcome it. Getting a second opinion is not a sign of distrust; it is a sign of a well-informed patient.
Dr. Senthil's clinic is frequently approached for second opinions by patients diagnosed elsewhere in Tamil Nadu and from other states. You are welcome to bring your existing reports.
Uterine cancer treatment in Chennai has evolved significantly. The range of options available today and the ability to combine them in precise, personalized ways means that outcomes are better than they were even a decade ago. The right treatment depends on your stage, the type of cancer, your overall health, and your personal priorities. Every treatment plan at Dr. Senthil's clinic is discussed openly before anything is finalised. You will understand what is being recommended and why.
Surgery is the cornerstone of uterine cancer treatment for most patients. The standard procedure is a total hysterectomy with bilateral salpingo-oophorectomy removal of the uterus, cervix, both ovaries, and both fallopian tubes. Nearby lymph nodes are also often removed and examined. Today, this surgery is increasingly performed using minimally invasive techniques laparoscopic or robotic-assisted surgery which means smaller incisions, significantly less pain, shorter hospital stays, and faster recovery compared to open surgery. The oncologic outcome is the same, but the patient's experience is considerably better.
Radiation therapy uses high energy beams to destroy cancer cells. In uterine cancer, it is most commonly used after surgery to reduce the risk of the cancer returning in the pelvis.
In some cases where surgery is not possible due to other medical conditions, radiation may be used as the primary treatment. This is decided on a case by case basis.
Chemotherapy is typically recommended for advanced-stage uterine cancer (Stage III or IV) or for certain high grade tumour types that carry a higher risk of spreading. It is usually given after surgery in cycles most commonly Carboplatin and Paclitaxel and can be combined with radiation therapy for better effect. Side effects are real but manageable. You will be given a plan to address each one before you begin treatment, not after you experience them.
Some types of uterine cancer particularly low-grade endometrioid cancers are hormone-sensitive. In these cases, hormonal treatments such as progestins or hormonal IUDs can slow or stop tumour growth. Hormone therapy is also an option for women who cannot undergo surgery due to other medical conditions, and in some early-stage cases for younger women who want to preserve fertility.
For patients whose cancer has come back after initial treatment or who have advanced disease, newer treatments offer meaningful options:
Before recommending any of these, tumour testing is done to identify which specific genetic or molecular features are present. This is what makes treatment genuinely personalised rather than generic.
For younger women diagnosed with early stage, low grade endometrial cancer who have a strong desire to have children, fertility-sparing treatment may be an option. This involves using high-dose progestin therapy (often via a hormonal IUD or oral medication) to control the cancer without removing the uterus.
This approach requires very careful patient selection, close monitoring, and a clear understanding that it is a temporary strategy surgery is generally still recommended once the family is complete. This conversation must happen at the very first consultation, before any treatment begins.
Uterine cancer cannot be completely prevented, but the risk can be meaningfully reduced. And unlike many cancers, it often gives clear signals early which means prevention and early detection are genuinely achievable goals for most women.
Unlike cervical cancer, there is no standard screening test recommended for all women. However, certain situations call for proactive evaluation:
If in doubt, an annual pelvic examination with your gynaecologist is the minimum baseline. Know your body well enough to notice when something changes.
A general gynaecologist is usually the first person you see when a symptom appears. They will order initial investigations and refer you if something concerning is found. But once a uterine mass, abnormal biopsy result, or thickened endometrium is identified that is when the right next step is seeing a gynaecologic oncologist.
A gynaecologist manages reproductive health across a wide range of conditions pregnancy, menstrual problems, infections, and benign tumours. A gynaecologic oncologist is a specialist who has done additional training specifically in cancers of the female reproductive system and spends their entire practice treating and operating on exactly these conditions. When cancer is confirmed or seriously suspected, the depth of experience a gynaecologic oncologist brings in surgery, in chemotherapy protocols, in reading biopsy reports, in knowing when to combine treatments makes a direct difference to outcomes.
Your first appointment is a conversation, not a verdict. Bring all reports ultrasound scans, biopsy results, blood tests, referral letters and bring your questions, however basic they feel. No question is too small when it is your health. By the end of the appointment, you will know: what the diagnosis is, what stage it is likely to be, what treatment options are available for your specific situation, and a realistic timeline for the next steps. You will leave with clarity not more confusion.
Choosing your oncologist is one of the most consequential decisions you will make. It is worth taking a moment to understand what distinguishes an experienced gynaecologic oncologist from a general surgeon or gynaecologist handling cancer cases.
Dr. Senthil Kumar Ravichandren is a specialist in surgical and medical oncology with a focused practice in cancers of the female reproductive system uterine, ovarian, cervical, and vulvar cancers. His experience spans the full range of gynaecologic cancer surgeries, including minimally invasive laparoscopic and robotic-assisted procedures, complex cytoreductive surgeries, and HIPEC for advanced cases. The depth of this surgical experience particularly in gynaecological cancer treatment in Chennai means patients receive not just technically sound care, but judgment built from handling hundreds of similar cases.
Every case referred to Dr. Senthil's clinic is reviewed by a multidisciplinary team surgical oncology, medical oncology, radiation oncology, pathology, and nutrition before a treatment plan is finalised. This is not standard practice everywhere. It should be. Patients are not managed through a protocol. They are managed as individuals with a specific diagnosis, a specific set of concerns, and a life outside the hospital that matters.
Many patients travelling from Madurai, Salem, Trichy, Coimbatore, or from abroad for uterine cancer treatment in Chennai ask the same question: is it worth coming here? The answer for complex surgeries, for access to minimally invasive procedures, for targeted therapy, and for the depth of gynaecologic oncology expertise available is consistently yes.
If you are considering travelling to Chennai for treatment, please contact the clinic ahead of your visit. We can arrange for your reports to be reviewed before you make the journey, and can help coordinate appointments to reduce the number of trips needed.
Treatment ending is not the same as the journey ending. The weeks and months after surgery or chemotherapy involve physical recovery, hormonal adjustment, emotional processing, and learning to read your body in a new way. This section is for women who have completed treatment and for their families.
Most patients who undergo a laparoscopic hysterectomy spend two to three days in hospital. Open surgery typically requires five to seven days. Here is what recovery generally looks like:
Recovery varies. Some women feel close to normal within three weeks; others need longer. Both are valid. The goal is steady, gentle progress not a race.
When both ovaries are removed during surgery which is standard in most uterine cancer cases surgical menopause begins immediately. Unlike natural menopause, which unfolds gradually over years, surgical menopause is abrupt, and the symptoms can be intense: hot flashes, sleep disturbance, mood changes, joint pain, and vaginal dryness. For women whose cancer type is not hormone-sensitive, hormone replacement therapy (HRT) may be an option to manage these symptoms. For others, non-hormonal treatments and lifestyle strategies are available. This is a conversation to have with Dr. Senthil before surgery, so you are prepared for what comes after.
After uterine cancer treatment, regular follow-up is not optional it is how recurrence is caught early, when it is most treatable:
Each follow-up includes a pelvic examination and review of any symptoms. Scans are arranged if there are clinical concerns. CA-125 blood testing may also be used in selected cases.
